000 01338 a2200361 4500
005 20250513095234.0
264 0 _c19961025
008 199610s 0 0 eng d
022 _a0031-6865
024 7 _a10.1016/0031-6865(95)00036-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVial-Bernasconi, A C
245 0 0 _aIn vivo evaluation of an indomethacin monolithic, extended zero-order release hard-gelatin capsule formulation based on saturated polyglycolysed glycerides.
_h[electronic resource]
260 _bPharmaceutica acta Helvetiae
_cDec 1995
300 _a307-13 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xadministration & dosage
650 0 4 _aCapsules
650 0 4 _aCross-Over Studies
650 0 4 _aGelatin
650 0 4 _aGlycerides
650 0 4 _aHumans
650 0 4 _aIndomethacin
_xadministration & dosage
650 0 4 _aMale
700 1 _aBuri, P
700 1 _aDoelker, E
700 1 _aBeyssac, E
700 1 _aDuchaix, G
700 1 _aAiache, J M
773 0 _tPharmaceutica acta Helvetiae
_gvol. 70
_gno. 4
_gp. 307-13
856 4 0 _uhttps://doi.org/10.1016/0031-6865(95)00036-4
_zAvailable from publisher's website
999 _c8762538
_d8762538